Therapeutic effects of bach1 siRNA on human breast adenocarcinoma cell line.

CONCLUSION: Our results suggest that the bach1 can be considered as a potent adjuvant in breast cancer therapy.
PMID: 28092843 [PubMed - as supplied by publisher]

Source: Biomedicine and pharmacotherapy = Biomedecine and pharmacotherapie - January 12, 2017 Category: Drugs & Pharmacology Authors: Aletaha M, Mansoori B, Mohammadi A, Fazeli M, Baradaran B Tags: Biomed Pharmacother Source Type: research